Biology of Fibroblast Growth Factor 23: From Physiology to Pathology

Marie Courbebaisse1,2, Beate Lanske1,3

  • 1Division of Bone and Mineral Research OMII, Harvard School of Dental Medicine, Boston, Massachusetts 02115.

Insights

Fibroblast growth factor (FGF)23 regulates phosphate and vitamin D metabolism. High FGF23 levels, seen in kidney disease, can cause heart problems and increase mortality risk.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Fibroblast growth factor (FGF)23 is a hormone produced by bone cells.
  • FGF23 regulates phosphate and vitamin D metabolism by acting on the kidneys and parathyroid glands.
  • Its levels are often elevated in chronic kidney disease (CKD).

Purpose of the Study:

  • To review the physiology of FGF23.
  • To discuss the pathological consequences of abnormal FGF23 levels.
  • To highlight the association between high FGF23 and adverse health outcomes.

Main Methods:

  • Literature review of FGF23 physiology and pathology.
  • Analysis of FGF23's role in phosphate homeostasis.
  • Examination of FGF23's effects on renal and parathyroid function.

Main Results:

  • FGF23 inhibits renal phosphate reabsorption and calcitriol production.
  • It also suppresses parathyroid hormone (PTH) secretion.
  • Elevated FGF23 is linked to left ventricular hypertrophy (LVH) and increased mortality risk.

Conclusions:

  • FGF23 plays a critical role in mineral metabolism.
  • Dysregulation of FGF23 contributes to cardiovascular complications and mortality.
  • Understanding FGF23 is crucial for managing metabolic bone diseases and CKD complications.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K